Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery.


Journal

The lancet. Diabetes & endocrinology
ISSN: 2213-8595
Titre abrégé: Lancet Diabetes Endocrinol
Pays: England
ID NLM: 101618821

Informations de publication

Date de publication:
07 2020
Historique:
received: 15 04 2020
revised: 23 04 2020
accepted: 24 04 2020
pubmed: 11 5 2020
medline: 2 7 2020
entrez: 11 5 2020
Statut: ppublish

Résumé

The coronavirus disease 2019 pandemic is wreaking havoc on society, especially health-care systems, including disrupting bariatric and metabolic surgery. The current limitations on accessibility to non-urgent care undermine postoperative monitoring of patients who have undergone such operations. Furthermore, like most elective surgery, new bariatric and metabolic procedures are being postponed worldwide during the pandemic. When the outbreak abates, a backlog of people seeking these operations will exist. Hence, surgical candidates face prolonged delays of beneficial treatment. Because of the progressive nature of obesity and diabetes, delaying surgery increases risks for morbidity and mortality, thus requiring strategies to mitigate harm. The risk of harm, however, varies among patients, depending on the type and severity of their comorbidities. A triaging strategy is therefore needed. The traditional weight-centric patient-selection criteria do not favour cases based on actual clinical needs. In this Personal View, experts from the Diabetes Surgery Summit consensus conference series provide guidance for the management of patients while surgery is delayed and for postoperative surveillance. We also offer a strategy to prioritise bariatric and metabolic surgery candidates on the basis of the diseases that are most likely to be ameliorated postoperatively. Although our system will be particularly germane in the immediate future, it also provides a framework for long-term clinically meaningful prioritisation.

Identifiants

pubmed: 32386567
pii: S2213-8587(20)30157-1
doi: 10.1016/S2213-8587(20)30157-1
pmc: PMC7252156
pii:
doi:

Types de publication

Comparative Study Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

640-648

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

Surg Endosc. 2015 Mar;29(3):529-36
pubmed: 25037725
BMJ Open. 2018 Nov 8;8(11):e023206
pubmed: 30413509
Diabetes Care. 2016 Jun;39(6):902-11
pubmed: 27222548
Cell Signal. 2015 Feb;27(2):283-92
pubmed: 25446262
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
Immunol Lett. 2016 Aug;176:81-9
pubmed: 27269375
Obesity (Silver Spring). 2020 Apr;28(4):O1-O58
pubmed: 32202076
Diabetologia. 2017 Oct;60(10):1892-1902
pubmed: 28733906
Diabetes Care. 2007 Jul;30(7):1736-41
pubmed: 17468353
Circulation. 2016 Feb 16;133(7):639-49
pubmed: 26746176
Nat Rev Immunol. 2016 Feb;16(2):112-23
pubmed: 26806484
Otolaryngol Head Neck Surg. 2007 Dec;137(6):878-82
pubmed: 18036414
JAMA. 2011 Jun 15;305(23):2419-26
pubmed: 21666276
Appl Physiol Nutr Metab. 2011 Aug;36(4):570-6
pubmed: 21838602
Diabetes Care. 2010 Sep;33(9):1933-9
pubmed: 20805271
Nat Rev Immunol. 2019 May;19(5):282-290
pubmed: 30808985
Eur Respir Rev. 2019 Mar 14;28(151):
pubmed: 30872398
Lancet Diabetes Endocrinol. 2020 Jun;8(6):546-550
pubmed: 32334646
Diabetes Obes Metab. 2019 Sep;21(9):2058-2067
pubmed: 31050119
Ann Surg. 2019 Jan;269(1):95-101
pubmed: 28938270
Diabet Med. 2018 Mar;35(3):360-367
pubmed: 29055156
Diabetes Care. 2018 Feb;41(2):372-382
pubmed: 29358469
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Mol Cell Endocrinol. 2009 Apr 29;302(2):193-202
pubmed: 18948167
Obes Surg. 2019 Jan;29(1):221-229
pubmed: 30251094
Am J Epidemiol. 2006 Jun 1;163(11):1042-52
pubmed: 16611666
Clin Infect Dis. 2011 Feb 1;52(3):301-12
pubmed: 21208911
JAMA. 2003 Jan 8;289(2):187-93
pubmed: 12517229
Diabetes Care. 2012 Jun;35(6):1301-9
pubmed: 22432119
Cell. 2020 Apr 16;181(2):281-292.e6
pubmed: 32155444
JAMA Surg. 2019 Dec 1;154(12):e193732
pubmed: 31664427
N Engl J Med. 2017 Feb 16;376(7):641-651
pubmed: 28199805
J Am Coll Surg. 2007 Aug;205(2):248-55
pubmed: 17660071
Diabetes Care. 2020 Jan;43(Suppl 1):S98-S110
pubmed: 31862752
Lancet Diabetes Endocrinol. 2014 Jan;2(1):38-45
pubmed: 24579062
Diabetologia. 2015 Jul;58(7):1448-53
pubmed: 25924987
JAMA. 2015 Jun 9;313(22):2263-73
pubmed: 26057287
Diabetes Care. 2016 Jun;39(6):861-77
pubmed: 27222544
Obes Surg. 2016 Oct;26(10):2418-24
pubmed: 26932813
PLoS One. 2013 Sep 19;8(9):e75498
pubmed: 24069423
Sleep Breath. 2008 Mar;12(1):25-31
pubmed: 17684780
Am J Clin Nutr. 2012 Feb;95(2):297-308
pubmed: 22158731
N Engl J Med. 2007 Aug 23;357(8):753-61
pubmed: 17715409
JAMA. 2012 Sep 19;308(11):1132-41
pubmed: 22990272
Ann Surg. 2008 Jan;247(1):21-7
pubmed: 18156918
Nat Rev Gastroenterol Hepatol. 2017 Jan;14(1):32-42
pubmed: 27729660
BMJ. 2014 Jul 29;349:g4596
pubmed: 25239614
Ann Surg. 2008 Jul;248(1):10-5
pubmed: 18580201
Gastroenterology. 2015 Aug;149(2):379-88; quiz e15-6
pubmed: 25917783
Ann Intern Med. 2018 Sep 4;169(5):300-310
pubmed: 30083761
Diabetes Care. 2004 Jan;27(1):155-61
pubmed: 14693982
JAMA Surg. 2013 Dec;148(12):1109-15
pubmed: 24132685
JAMA Surg. 2013 Jun;148(6):555-62
pubmed: 23426865
Diabetes Care. 2020 Jun;43(6):1175-1177
pubmed: 32434895
Hepatology. 2016 Nov;64(5):1577-1586
pubmed: 27543837
Lancet. 2015 Sep 5;386(9997):964-73
pubmed: 26369473
Diabetes Obes Metab. 2018 Sep;20(9):2210-2219
pubmed: 29766634
N Engl J Med. 2010 Nov 25;363(22):2102-13
pubmed: 21105792
Obesity (Silver Spring). 2011 Jan;19(1):110-20
pubmed: 20559296
Ann Surg. 2016 Jul;264(1):73-80
pubmed: 27275778
JAMA. 2012 Jan 4;307(1):88-9
pubmed: 22215170
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Diabetologia. 2018 Feb;61(2):257-264
pubmed: 29224190
Front Horm Res. 2008;36:229-259
pubmed: 18230906
Lancet. 2017 Apr 8;389(10077):1399-1409
pubmed: 28237263
Am J Med. 2004 Jan 1;116(1):1-7
pubmed: 14706658
Ann Transl Med. 2017 Apr;5(7):161
pubmed: 28480197
JAMA. 2018 Jan 16;319(3):266-278
pubmed: 29340678
Diabet Med. 2015 Sep;32(9):1121-33
pubmed: 25683343
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
JAMA. 2020 May 12;323(18):1769-1770
pubmed: 32208485
CMAJ. 2011 Oct 4;183(14):E1059-66
pubmed: 21844111
Nature. 2009 Jan 29;457(7229):557-61
pubmed: 19136945
J Reprod Med. 1990 Dec;35(12):1117-23
pubmed: 2178190
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007340
pubmed: 20091629
BMJ. 2000 Aug 12;321(7258):405-12
pubmed: 10938048
Metabolism. 2018 Feb;79:64-76
pubmed: 29137912
Lancet Diabetes Endocrinol. 2019 Jul;7(7):549-559
pubmed: 31174993
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Health Qual Life Outcomes. 2018 Sep 19;16(1):189
pubmed: 30231882
Obes Surg. 2019 Mar;29(3):1031-1039
pubmed: 30591985
Ann Surg. 2020 Dec;272(6):1053-1059
pubmed: 30998538
Occup Environ Med. 2016 Dec;73(12):857-863
pubmed: 27484956
Ann Surg. 2014 Jan;259(1):117-22
pubmed: 23314274
Diabetes Care. 2018 Apr;41(4):670-679
pubmed: 29432125
Arch Surg. 2009 Oct;144(10):914-20
pubmed: 19841358
Ann Surg. 2003 Oct;238(4):467-84; discussion 84-5
pubmed: 14530719
Nat Med. 2020 Apr;26(4):485-497
pubmed: 32127716

Auteurs

Francesco Rubino (F)

Department of Diabetes, School of Life Course Sciences, King's College London, London, UK; Bariatric and Metabolic Surgery, King's College Hospital, London, UK. Electronic address: francesco.rubino@kcl.ac.uk.

Ricardo V Cohen (RV)

Center for the treatment of Obesity and Diabetes, Oswaldo Cruz German Hospital, Sao Paulo, Brazil.

Geltrude Mingrone (G)

Department of Diabetes, School of Life Course Sciences, King's College London, London, UK; Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Università Cattolica del Sacro Cuore, Rome, Italy.

Carel W le Roux (CW)

Diabetes Complications Research Centre, Conway Institute, University College of Dublin, Dublin, Ireland.

Jeffrey I Mechanick (JI)

The Marie-Josee and Henry R Kravis Center for Clinical Cardiovascular Health at Mount Sinai Heart, New York, NY, USA; Divisions of Cardiology and Endocrinology, Diabetes, and Bone Disease, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

David E Arterburn (DE)

Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA; Department of Medicine, Division of General Internal Medicine, University of Washington, Seattle, WA, USA.

Josep Vidal (J)

Endocrinology and Nutrition Department, Hospital Clinic Universitari, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain; Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas, Instituto de Salud Carlos III, Madrid, Spain.

George Alberti (G)

Department of Endocrinology and Metabolism, Imperial College, London, UK.

Stephanie A Amiel (SA)

Department of Diabetes, School of Life Course Sciences, King's College London, London, UK.

Rachel L Batterham (RL)

Centre for Obesity Research, University College London, London, UK; University College London Hospitals Bariatric Centre for Weight Management and Metabolic Surgery, London, UK; National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, UK.

Stefan Bornstein (S)

Paul Langerhans Institute Dresden, Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Faculty of Medicine, Technical University Dresden, Dresden, Germany.

Ghassan Chamseddine (G)

Bariatric and Metabolic Surgery, King's College Hospital, London, UK.

Stefano Del Prato (S)

Department of Clinical and Experimental Medicine, Section of Metabolic Diseases and Diabetes, University of Pisa, Pisa, Italy.

John B Dixon (JB)

Iverson Health Innovation Research Institute, Swinburne University, Melbourne, VIC, Australia.

Robert H Eckel (RH)

Division of Endocrinology, Metabolism and Diabetes and Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.

David Hopkins (D)

King's Health Partners' Institute of Diabetes, Endocrinology and Obesity, London, UK.

Barbara M McGowan (BM)

Institute of Diabetes, Endocrinology and Obesity, Guy's and St Thomas' National Health Service Foundation Trust, London, UK.

An Pan (A)

Department of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Ameet Patel (A)

Bariatric and Metabolic Surgery, King's College Hospital, London, UK.

François Pattou (F)

European Genomic Institute for Diabetes, Lille, France; Translational Research for Diabetes, University of Lille, Inserm, Centre Hospitalier Regional Universitaire, Lille, France.

Philip R Schauer (PR)

Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, LA, USA.

Paul Z Zimmet (PZ)

Department of Diabetes, Central Clinical School, Monash University, Melbourne, VIC, Australia.

David E Cummings (DE)

University of Washington Medicine Diabetes Institute, University of Washington, Seattle, WA, USA; Weight Management Program, Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, WA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH